Sonoma Pharmaceuticals, Inc. (SNOA) SEC Filing 8-K Material Event for the period ending Wednesday, September 25, 2019

Sonoma Pharmaceuticals, Inc.

CIK: 1367083 Ticker: SNOA

View differences made from one to another to evaluate Sonoma Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sonoma Pharmaceuticals, Inc..


Assess how Sonoma Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sonoma Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: SNOA
CIK: 1367083
Form Type: 8-K Corporate News
Accession Number: 0001683168-19-003115
Submitted to the SEC: Tue Oct 01 2019 5:16:53 PM EST
Accepted by the SEC: Tue Oct 01 2019
Period: Wednesday, September 25, 2019
Industry: Pharmaceutical Preparations
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: